Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Spinocerebellar Ataxias: later-stage trial registry
1 of 6 indexed Spinocerebellar Ataxias trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Spinocerebellar Ataxias: 6 US clinical trials tracked, 1 recruiting.
Spinocerebellar Ataxias is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Biohaven Pharmaceuticals, running 2 of these trials.
Enrollment posture brief
Registry condition spinocerebellar-ataxias
OPEN 1 | RECR 17% | LATE 2 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Spinocerebellar Ataxias lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Spinocerebellar Ataxias on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Spinocerebellar Ataxias is recruiting below its size-band peers.
1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Spinocerebellar Ataxias research.
Biohaven Pharmaceuticals accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Spinocerebellar Ataxias enrolment sits around 299 participants.
Median target enrolment is 299 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Spinocerebellar Ataxias splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Mayo Clinic
NCT04529252
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
Biohaven Therapeutics
NCT06529146
Troriluzole in Adult Participants With Spinocerebellar Ataxia
Biohaven Pharmaceuticals
NCT03701399
Open Pilot Trial of BHV-4157
University of California, Los Angeles
NCT03408080
Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
Biohaven Pharmaceuticals
NCT02960893
Aerobic Exercise, Balance Training, and Ataxia
Columbia University
NCT03745248
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Spinocerebellar Ataxias records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Spinocerebellar Ataxias trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Spinocerebellar Ataxias page
6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Spinocerebellar Ataxias trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Biohaven Pharmaceuticals sponsors the most Spinocerebellar Ataxias trials on record, review their full trial history before evaluating a specific study. See Biohaven Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Spinocerebellar Ataxias condition card totals 6 registered trials; most-linked intervention BHV-4157; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.